Risks for MDS/Leukemia Increased for Survivors of Common Lymphoid Neoplasms
THURSDAY, Aug. 17, 2023 (HealthDay News) — Survivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more recent years, accordin…
Learn MoreUnos medicamentos inmunitarios ofrecen esperanzas contra los cánceres de pene
MARTES, 15 de agosto de 2023 (HealthDay News) — Los hombres que tienen un raro cáncer de pene quizá cuenten con una nueva opción de tratamiento, según unos investigadores que encontraron potencial en la inmunoterapia. Este nuevo estudio se enfocó en …
Learn MoreAtezolizumab Monotherapy Beneficial for NSCLC Ineligible for Platinum-Based Chemo
TUESDAY, Aug. 15, 2023 (HealthDay News) — For patients with non-small cell lung cancer (NSCLC) ineligible for platinum-based chemotherapy, first-line atezolizumab monotherapy is associated with improved overall survival compared to single-agent chemo…
Learn MoreImmune-Based Cancer Drugs Offer Hope Against Penile Cancers
TUESDAY, Aug. 15, 2023 (HealthDay News) — Men who have a rare cancer of the penis may have a new treatment option, according to researchers who found promise in immunotherapy.This new study focused on cancer that was locally advanced or had spread (m…
Learn MoreCombo Therapy Could Treat Oral Melanomas in Dogs
TUESDAY, June 27, 2023 (HealthDay News) — Could a treatment combo that improves the odds against melanoma for humans work in dogs?Yes, claims a new study that found radiotherapy followed by immunotherapy extended survival in canine melanoma patients….
Learn More¿Podría la pérdida del cromosoma Y ayudar a acelerar los cánceres en los hombres?
MIÉRCOLES, 21 de junio de 2023 (HealthDay News) — Todo el mundo sabe que las pérdidas forman parte del envejecimiento masculino: la pérdida del cabello, del tono muscular, de la visión o del oído. Pero, al envejecer, los hombres también comienzan a p…
Learn MoreCould Loss of the Y Chromosome Help Speed Cancers in Men?
WEDNESDAY, June 21, 2023 (HealthDay News) — It’s common knowledge that loss is a part of male aging — loss of hair, loss of muscle tone, loss of vision or hearing.But men growing older also start losing the very thing that makes them biological males…
Learn MoreFecal Microbiota Transplant Effective for Immune-Mediated Colitis
FRIDAY, June 16, 2023 (HealthDay News) — For patients with refractory immune checkpoint inhibitor (ICI)-induced colitis, fecal microbiota transplantation (FMT) is an effective treatment, according to a study published in the June 14 issue of Science …
Learn MoreDos años de inmunoterapia para un cáncer de pulmón avanzado podrían ser suficientes, según un estudio
VIERNES, 9 de junio de 2023 (HealthDay News) — Las perspectivas de supervivencia han aumentado de forma significativa para los pacientes con un cáncer de pulmón en etapa tardía, desde la llegada de medicamentos conocidos como inhibidores de puntos de…
Learn More2 Years of Immunotherapy for Advanced Lung Cancer Might Be Enough: Study
FRIDAY, June 9, 2023 (HealthDay News) — For patients battling late-stage lung cancer, prospects for survival have improved significantly since the advent of medications known as immune checkpoint inhibitors.But exactly how long patients with advanced…
Learn More